Siga Technologies INC Income (Loss) from Continuing Operations before Income Taxes, Domestic
Siga Technologies INC (SIGA) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $30.33 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-10
- Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for the quarter ending 2017-09-30 was $9.70M, a 5.43% increase year-over-year.
- Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for the quarter ending 2017-06-30 was $7.40M, a 22.92% decline year-over-year.
- Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for the quarter ending 2017-03-31 was $8.50M, a 18.27% decline year-over-year.
- Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for the quarter ending 2016-09-30 was $9.20M, a 64.29% increase year-over-year.
- Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $30.33M, a 60.11% decline from fiscal 2024.
- Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $76.04M, a 13.30% decline from fiscal 2023.
- Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $87.70M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|---|---|
| 2025-12-31 | $30.33M 10-K · filed 2026-03-10 | |||
| 2024-12-31 | $76.04M 10-K · filed 2026-03-10 | |||
| 2023-12-31 | $87.70M 10-K · filed 2026-03-10 | |||
| 2017-09-30 | $9.70M 10-Q · filed 2017-11-07 | $17.10M derived: sum of 2 quarters · filed 2017-11-07 | $25.60M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $7.40M 10-Q · filed 2017-08-03 | $15.90M 10-Q · filed 2017-08-03 | ||
| 2017-03-31 | $8.50M 10-Q · filed 2017-05-04 | |||
| 2016-09-30 | $9.20M 10-Q · filed 2016-11-02 | $18.80M derived: sum of 2 quarters · filed 2016-11-02 | $29.20M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $9.60M 10-Q · filed 2016-08-08 | $20.00M 10-Q · filed 2016-08-08 | ||
| 2016-03-31 | $10.40M 10-Q · filed 2016-05-04 | |||
| 2015-09-30 | $5.60M 10-Q · filed 2015-10-27 | $12.10M derived: sum of 2 quarters · filed 2015-10-27 | $19.10M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $6.50M 10-Q · filed 2015-08-04 | $13.60M 10-Q · filed 2015-08-04 | ||
| 2015-03-31 | $7.10M 10-Q · filed 2015-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |